Program

microscope-275984_1280

ONCOBELL 2nd INTERNATIONAL SYMPOSIUM

«Building bridges between science, cancer medicine and persons»

Barcelona, September 19-20th, 2022. Auditorium, Bellvitge University Hospital.

0000

08.00h – 08.45h

REGISTRATION

08.45h – 09.00h

WELCOME

09.00h – 10.00h

OPENING KEYNOTE LECTURE 

Modeling  prostate cancer metastasis in genetically engineered mouse models. Cory Abate-ShenColumbia University Medical Center, New York, USA .

10.00h – 12.00h

SESSION 1: IMMUNE SYSTEM, INFLAMMATION AND CANCER

Chaired by:  Ramón Alemany, Oncobell Program, IDIBELL – ICO.

CD137-based immunotherapy from bench to bed and back to the future. Ignacio Melero, Clínica Universitaria de Navarra, Navarra.

(To be announced). Josep Maria Piulats, Oncobell Program, IDIBELL – ICO.

Role of the ecosystem in hepatobiliary cancer progression. Gianluigi Giannelli, GG National Institute of Gastroenterology Saverio De Bellis, Castellana Grotte, Bari, Italy.

Protumorogenic consequences of starvation in the tumor microenvironment. Cristina Muñoz-Pinedo, Oncobell Program, IDIBELL- UB.

12.00h – 12.30h

COFFE BREAK

12.30h – 13.30h

ROUND TABLE: CLINICAL INNOVATION: TECHNOLOGY AND MANAGEMENT

Chaired by:  Ferran Guedea,  Oncobell Program, IDIBELL – ICO  & Jordi Ponce, Oncobell Program,  IDIBELL- HUB..

(To be announced). Jean Bourhis, CHUV, Lausanne, Switzerland

Technological and process innovation. Robotics and enhanced recovery after surgery (ERAS). Jordi Ponce, Oncobell Program, IDIBELL- HUB

Digital Pathology as a tool to improvepathology workload, diagnosis and research. The example of DigiPATcs. Xavier Matias-Guiu, Oncobell Program, IDIBELL – HUB.

Fast track recovery programme FEDER

13.30h – 16.00h

POSTER SESSION & LUNCH

14:00 – 15:00 Even-numbered posters

15:00 – 16:00 Odd-numbered posters

16.00h – 18.00h

SESSION 2: DNA REPAIR AND GENOMICS IN CANCER

Chaired by: Conxi Lázaro, Oncobell Program, IDIBELL- ICO.

The chronic lymphocytic leukemia epigenome: biological insights and clinical applications. Iñaki Martín Subero, IDIBAPS, Barcelona.

Latest insights into colorectal cancer predisposition. Laura Valle, Oncobell Program, IDIBELL- ICO.

Understanding oncogenesis across biological scales: from individual mutations to tissue structure. Eduard Porta, BSC, Barcelona.

Clinical implications of DNA repair defects in prostate cancer. Elena Castro, Hospital 12 de Octubre, Madrid, Spain

0000

08.30h – 10.30h

SESSION 3: TARGETING SIGNALING PATHWAYS

Chaired by: Purificación Muñoz, Oncobell Program, IDIBELL.

ER stress and inflammation pave the way to pancreatic cancer. Francisco Real, CNIO, Madrid, Spain.

Identification of new oncogenic drivers involved in GTPase signaling. Xosé R. Bustelo, CSIC, Universidad de Salamanca.

Understanding chemotherapy resistance in T cell Acute lymphoblastic leukemia. Anna Bigas, IMIM, Barcelona, Spain.

Predictive Power of TGF-β Signaling in Cancer Therapy. Mary Helen Barcellos-Hoff, University of California, (UCSF), USA.

10.30h – 11.00h

COFFE BREAK

11.00h – 13.00h

SESSION 4: METASTASIS & RESPONSE TO THERAPY

Chaired by: Alberto Villanueva, Oncobell Program, IDIBELL.- ICO

Imaging and targeting of premetastatic niches in melanoma. Marisol Soengas, CNIO, Madrid,

Ovarian cancer dissemination relies on PDGFRs and S1PR1 for tumorsphere formation and proliferation. Francesc Viñals, Oncobell Program, IDIBELL -UB- ICO,

Breast Cancer metástasis cell fate. Roger Gomis, IRB, Barcelona,

The amoeboid state as part of the epithelial to mesenchymal transition program in cancer. Vicky Sanz Moreno, Barts Cancer Institute, QMUL, London, UK.

13.00h – 14.00h

CLOSING KEYNOTE LECTURE

Exploiting immune surveillance to target colorectal cancer evolution and mutability. Alberto Bardelli, IFOM, Candiolo, Italy.

14.00h – 14.15h

CLOSING SESSION AND POSTER PRIZES

 

0000